Liquid biopsy

PANAMutyper™ c-Met (exon 14 skipping)

Ref. PNAR-7101

PANAMutyper™ c-Met (exon 14 skipping) is an in vitro diagnostic test kit to detect gene alteration in c-Met oncogene. The kit is developed to be used by the trained laboratory professionals, within the fully equipped laboratory environment, using the RNA derived from formalin-fixed paraffin-embedded (FFPE) tissue of…

Tests per card —
Packaging —
Contact us for product availability and technical details.

About the Product

PANAMutyper™ c-Met (exon 14 skipping) is an in vitro diagnostic test kit to detect gene alteration in c-Met oncogene. The kit is developed to be used by the trained laboratory professionals, within the fully equipped laboratory environment, using the RNA derived from formalin-fixed paraffin-embedded (FFPE) tissue of non-small cell lung cancer (NSCLC) patients.

PANAMutyper™ c-Met (exon 14 skipping) is intended as an aid for NSCLC patients who would be sensitive for receiving c-Met inhibitor therapy.

Technical Characteristics

C-MET Mutation 1
  • Amino Acid Change: p.D963_E1009del
  • Nucleotide change: mRNA exon 14 skipping
Procedure DNA ExtractionPCR SetupReal-time PCRResult Analysis

Key Features

  • Detect exon 14 skipping of c-Met mutation using 1 reaction tubes
  • One-step reverse-transcription qPCR
  • High sensitivity and specificity
  • Convenient testing with master mix format
  • Automated result analysis software

Technical Information

No technical information available for this product.

Compatibility

Compatible sample type: Formalin-fixed paraffin-embedded (FFPE) tissue

Compatible Real-Time PCR machine:

  • CFX96 (Bio-Rad)
  • QuantStudio® 5

Packaging

No packaging information available for this product.